Alkermes plc. (ALKS) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.85M; Additional Paid in Capital, Common StockUSD $3.11B; Treasury Stock, Common, ValueUSD $502.52M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.92M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.84M; Additional Paid in Capital, Common StockUSD $3.06B; Treasury Stock, Common, ValueUSD $501.43M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.91M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.81M; Additional Paid in Capital, Common StockUSD $3.00B; Treasury Stock, Common, ValueUSD $450.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.10M.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.80M; Additional Paid in Capital, Common StockUSD $2.97B; Treasury Stock, Common, ValueUSD $450.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.06M.
Alkermes plc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Treasury Stock, Value USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.85M | $3.11B | $502.52M | $-2.92M | $-800.77M | $1.81B | 17.16M | (m) | 3 month · $31.34M | 3 month · 0.00 | 6 month · 27.82 | (m) | (m) | (m) |
| 2026-03-31 | $1.84M | $3.06B | $501.43M | $-2.91M | $-801.27M | $1.75B | 17.13M | 3 month · $27.70M | 3 month · $34.95M | 3 month · 1.00M | 3 month · 27.82 | (m) | (m) | (m) |
| 2025-12-31 | $1.81M | $3.00B | $450.29M | $-2.10M | $-734.79M | $1.82B | 15.40M | (m) | 12 month · $100.41M | 12 month · 0.00 | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.80M | $2.97B | $450.02M | $-1.06M | $-784.13M | $1.73B | 15.40M | (m) | 3 month · $25.43M | 9 month · 0.00 | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.80M | $2.94B | $449.71M | $-1.40M | $-866.90M | $1.62B | 15.38M | (m) | 3 month · $25.44M | 6 month · 0.00 | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.80M | $2.91B | $448.04M | $-1.46M | $-953.99M | $1.51B | 15.33M | (m) | 3 month · $22.88M | 3 month · 0.00 | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.77M | $2.86B | $419.25M | $-1.97M | $-976.46M | $1.46B | 14.49M | 12 month · $200.28M | 12 month · $96.42M | 12 month · 7.90M | 12 month · 25.33 | (m) | (m) | (m) |
| 2024-09-30 | $1.76M | $2.83B | $418.91M | $425.00K | $-1.12B | $1.29B | 14.48M | 3 month · $115.59M | 3 month · $22.07M | 3 month · 4.40M 9 month · 7.90M | 3 month · 26.22 9 month · 25.33 | (m) | (m) | (m) |
| 2024-06-30 | $1.76M | $2.80B | $303.02M | $-3.59M | $-1.22B | $1.28B | 10.07M | 3 month · $84.69M 6 month · $84.70M | 3 month · $20.61M | 6 month · 3.50M | 6 month · 24.22 | (m) | (m) | (m) |
| 2024-03-31 | $1.76M | $2.78B | $217.69M | $-3.60M | $-1.31B | $1.25B | 6.55M | (m) | 3 month · $32.86M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.73M | $2.74B | $189.34M | $-3.11M | $-1.34B | $1.20B | 5.59M | (m) | 12 month · $100.87M | 12 month · 0.00 | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.72M | $3.00B | $186.94M | $-6.07M | $-1.46B | $1.36B | 5.50M | (m) | 3 month · $23.71M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.72M | $2.98B | $186.15M | $-7.44M | $-1.50B | $1.28B | 5.48M | (m) | 3 month · $28.52M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.72M | $2.94B | $185.61M | $-8.13M | $-1.74B | $1.01B | 5.46M | (m) | 3 month · $22.78M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.69M | $2.91B | $160.86M | $-10.89M | $-1.70B | $1.04B | 4.57M | (m) | 12 month · $95.18M | 12 month · 0.00 | (m) | (m) | (m) | (m) |
| 2022-09-30 | $1.69M | $2.89B | $160.56M | $-12.84M | $-1.67B | $1.04B | 4.56M | (m) | 3 month · $26.32M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $1.69M | $2.86B | $160.24M | $-10.49M | $-1.61B | $1.08B | 4.55M | (m) | 3 month · $23.64M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $1.68M | $2.82B | $159.73M | $-8.23M | $-1.58B | $1.08B | 4.53M | (m) | 3 month · $18.49M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $1.66M | $2.80B | $142.66M | $-3.72M | $-1.54B | $1.11B | 3.85M | (m) | 12 month · $87.40M | 12 month · 0.00 | (m) | (m) | (m) | (m) |
| 2021-09-30 | $1.65M | $2.78B | $139.72M | $-2.47M | $-1.54B | $1.10B | 3.75M | (m) | 3 month · $25.70M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $1.65M | $2.75B | $137.21M | $-2.22M | $-1.51B | $1.10B | 3.67M | (m) | 3 month · $26.92M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $1.64M | $2.70B | $136.50M | $-1.95M | $-1.52B | $1.05B | 3.64M | (m) | 3 month · $15.55M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.62M | $2.69B | $126.09M | $-1.35M | $-1.49B | $1.07B | 3.11M | (m) | 12 month · $91.26M | (m) | (m) | (m) | (m) | (m) |
| 2020-11-18 | (m) | (m) | (m) | (m) | (m) | (m) | 3.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.62M | $2.66B | $125.99M | $-760.00K | $-1.45B | $1.08B | 3.10M | (m) | 3 month · $22.71M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $1.62M | $2.64B | $125.79M | $-101.00K | $-1.45B | $1.06B | 3.09M | (m) | 3 month · $23.14M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.61M | $2.61B | $125.67M | $-1.50M | $-1.42B | $1.06B | 3.08M | (m) | 3 month · $20.12M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.60M | $2.59B | $118.39M | $-1.82M | $-1.38B | $1.09B | 2.71M | (m) | 12 month · $99.70M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $1.60M | $2.56B | $118.30M | $-1.64M | $-1.38B | $1.07B | 2.71M | (m) | 3 month · $26.30M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $1.59M | $2.53B | $118.14M | $-1.61M | $-1.32B | $1.09B | 2.70M | (m) | 3 month · $28.26M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $1.59M | $2.50B | $117.95M | $-2.51M | $-1.28B | $1.10B | 2.69M | (m) | 3 month · $24.81M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $1.58M | $2.47B | $108.97M | $-3.28M | $-1.19B | $1.17B | 2.42M | (m) | 12 month · $107.71M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $1.57M | $2.43B | $105.13M | $-3.67M | $-1.18B | $1.15B | 2.31M | (m) | 3 month · $25.41M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $1.57M | $2.41B | $105.09M | $-3.98M | $-1.14B | $1.16B | 2.31M | (m) | 3 month · $30.95M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $1.57M | $2.37B | $105.07M | $-4.13M | $-1.11B | $1.16B | 2.31M | (m) | 3 month · $20.18M | (m) | (m) | (m) | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $900.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.56M | $2.34B | $89.35M | $-3.79M | $-1.04B | $1.20B | 2.05M | (m) | 12 month · $83.18M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $1.55M | $2.31B | $89.31M | $-3.25M | $-1.03B | $1.19B | 2.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $1.55M | $2.29B | $89.22M | $-3.33M | $-998.30M | $1.20B | 2.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $1.55M | $2.26B | $85.83M | $-3.20M | $-955.30M | $1.22B | 1.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.54M | $2.23B | $72.64M | $-3.27M | $-947.94M | $1.21B | 1.76M | (m) | 12 month · $94.46M | (m) | (m) | (m) | 12 month · $1.83M | (m) |
| 2016-09-30 | $1.53M | $2.21B | $67.25M | $-2.81M | $-926.80M | $1.21B | 1.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $1.53M | $2.18B | $67.09M | $-2.55M | $-864.12M | $1.24B | 1.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $1.52M | $2.15B | (m) | $-2.86M | $-816.92M | $1.27B | (m) | (m) | (m) | (m) | (m) | $61.96M | (m) | 1.53M |
| 2015-12-31 | $1.52M | $2.11B | $58.66M | $-3.79M | $-739.50M | $1.31B | 1.43M | (m) | 12 month · $97.62M | (m) | (m) | $58.66M | 12 month · $28.58M | 1.43M |
| 2015-09-30 | $1.51M | $2.09B | (m) | $-2.71M | $-670.12M | $1.37B | (m) | (m) | (m) | (m) | (m) | $49.60M | (m) | 1.28M |
| 2015-06-30 | $1.50M | $2.04B | (m) | $-2.73M | $-589.10M | $1.40B | (m) | (m) | (m) | (m) | (m) | $49.38M | (m) | 1.28M |
| 2015-03-31 | $1.49M | $2.00B | (m) | $-2.65M | $-542.99M | $1.42B | (m) | (m) | (m) | (m) | (m) | $36.75M | (m) | 1.07M |
| 2014-12-31 | $1.48M | $1.94B | (m) | $-3.14M | $-512.34M | $1.40B | (m) | (m) | 12 month · $59.91M | (m) | (m) | $32.05M | 12 month · $32.37M | 1.01M |
| 2014-09-30 | $1.47M | $1.91B | (m) | $-2.87M | $-542.85M | $1.33B | (m) | (m) | (m) | (m) | (m) | $30.88M | (m) | 982.73K |
| 2014-06-30 | $1.46M | $1.89B | (m) | $-2.71M | $-502.89M | $1.35B | (m) | (m) | (m) | (m) | (m) | $30.86M | (m) | 982.24K |
| 2014-03-31 | $1.45M | $1.85B | (m) | $8.04M | $-506.63M | $1.34B | (m) | (m) | (m) | (m) | (m) | $17.96M | (m) | 692.69K |
| 2013-12-31 | $1.38M | $1.55B | (m) | $10.57M | $-482.27M | $1.07B | (m) | (m) | 9 month · $33.27M | (m) | (m) | $17.83M | 9 month · $11.39M | 689.95K |
| 2013-09-30 | $1.37M | $1.52B | (m) | $5.58M | $-500.35M | $1.02B | (m) | (m) | (m) | (m) | (m) | $14.40M | (m) | 596.42K |
| 2013-06-30 | $1.35M | $1.49B | (m) | $-2.92M | $-492.59M | $981.94M | (m) | (m) | (m) | (m) | (m) | $13.90M | (m) | 581.35K |
| 2013-03-31 | $1.34M | $1.46B | (m) | $-2.52M | $-499.92M | $952.37M | (m) | (m) | 12 month · $34.93M | (m) | (m) | $5.38M | 12 month · $8.87M | 313.50K |
| 2012-12-31 | $1.32M | $1.43B | (m) | $-2.66M | $-502.92M | $919.94M | (m) | (m) | (m) | (m) | (m) | $5.38M | (m) | 313.25K |
| 2012-09-30 | $1.31M | $1.41B | (m) | $-2.79M | $-519.18M | $885.01M | (m) | (m) | (m) | (m) | (m) | $3.89M | (m) | 237.53K |
| 2012-06-30 | $1.31M | $1.39B | (m) | $-2.93M | $-502.47M | $882.49M | (m) | (m) | (m) | (m) | (m) | $3.89M | (m) | 237.53K |
| 2012-03-31 | $1.30M | $1.38B | (m) | $-2.71M | $-524.91M | $853.85M | (m) | (m) | 12 month · $28.61M | (m) | (m) | $571.00K | 12 month · $4.33M | 35.08K |
| 2011-12-31 | (m) | $1.37B | (m) | $-2.92M | $-461.55M | $904.85M | (m) | (m) | 9 month · $21.81M | (m) | (m) | $417.00K | 9 month · $3.13M | 27.03K |
| 2011-09-30 | $1.29M | $1.36B | (m) | $-2.92M | $-446.72M | $909.68M | (m) | $114.00M | 6 month · $12.64M | 8.87M | (m) | $0.00 | 6 month · $3.13M | (m) |
| 2011-03-31 | $1.05M | $936.29M | (m) | $-3.01M | $-411.23M | $392.02M | (m) | (m) | 12 month · $19.82M | (m) | (m) | $131.09M | (m) | 10.07M |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | $396.32M | (m) | (m) | 9 month · $15.13M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | $402.09M | (m) | (m) | 6 month · $9.35M | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | $412.62M | (m) | 12 month · $2.68M | 12 month · $14.11M | (m) | (m) | (m) | 12 month · $246.00K | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | $434.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |